New drug application accepted by FDA for GSK's momelotinib : vimarsana.com

Therapy for the treatment of myelofibrosis has received significant results from phase 3 trial - News - PharmaTimes

Related Keywords

United States , United Kingdom , American , , American Society Of Clinical Oncology Annual Meeting , European Hematology Association , Drug Administration , Prescription Drug User Fee Act , Clinical Oncology Annual Meeting , Sierra Oncology , Fda , Sk , Omelotinib ,